<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03060954</url>
  </required_header>
  <id_info>
    <org_study_id>PSM29</org_study_id>
    <nct_id>NCT03060954</nct_id>
  </id_info>
  <brief_title>Non-Inferiority Study Comparing MINI WELL READY® and FineVision® in Patients With Cataract Surgery</brief_title>
  <official_title>A Multicentre, Controlled, Randomised, Single-blind, Two-armed Trial Evaluating the Visual Performance, Quality of Vision and Subjective Outcomes After Bilateral Implantation of MINI WELL Ready® or FineVision® in Patients With Cataract Surgery.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>SIFI SpA</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Opera CRO, a TIGERMED Group Company</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>SIFI SpA</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Interventional, Multicentre, controlled, randomized, single blind, twoarmed non-inferiority
      trial
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To evaluate the non-inferiority of the progressive extended depth of focus Intraocular Lens
      MINI WELL READY® in terms of visual performance, quality of vision and subjective outcomes
      versus the trifocal Intraocular Lens FineVision® after a follow up period of 2-6 months.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 10, 2019</start_date>
  <completion_date type="Anticipated">September 2020</completion_date>
  <primary_completion_date type="Anticipated">April 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Defocus curve - binocular</measure>
    <time_frame>6 months</time_frame>
    <description>Defocus curve assessment</description>
  </primary_outcome>
  <other_outcome>
    <measure>Refraction</measure>
    <time_frame>6 months</time_frame>
    <description>Ocular refraction evaluation</description>
  </other_outcome>
  <other_outcome>
    <measure>Visual Acuity Evaluation</measure>
    <time_frame>6 months</time_frame>
    <description>Uncorrected Distance Visual Acuity (UDVA)</description>
  </other_outcome>
  <other_outcome>
    <measure>Visual Acuity Evaluation</measure>
    <time_frame>6 months</time_frame>
    <description>Corrected Distance Visual Acuity (CDVA) Uncorrected Intermediate Visual Acuity (UIVA)</description>
  </other_outcome>
  <other_outcome>
    <measure>Visual Acuity Evaluation</measure>
    <time_frame>6 months</time_frame>
    <description>Distance Corrected Intermediate Visual Acuity (DCIVA)</description>
  </other_outcome>
  <other_outcome>
    <measure>Visual Acuity Evaluation</measure>
    <time_frame>6 months</time_frame>
    <description>Uncorrected Near Visual Acuity (UNVA)</description>
  </other_outcome>
  <other_outcome>
    <measure>Visual Acuity Evaluation</measure>
    <time_frame>6 months</time_frame>
    <description>Distance Corrected Near Visual Acuity (DCNVA)</description>
  </other_outcome>
  <other_outcome>
    <measure>Reading speed</measure>
    <time_frame>6 months</time_frame>
    <description>Reading speed performance</description>
  </other_outcome>
  <other_outcome>
    <measure>Halometry</measure>
    <time_frame>6 months</time_frame>
    <description>Halos evaluation</description>
  </other_outcome>
  <other_outcome>
    <measure>Contrast sensitivity</measure>
    <time_frame>6 months</time_frame>
    <description>Contrast sensitivity evaluation</description>
  </other_outcome>
  <other_outcome>
    <measure>Subject satisfaction questionnaire - VF-11R</measure>
    <time_frame>6 months</time_frame>
    <description>Subject satisfaction questionnaire - VF-11R &quot;revised version&quot;:
Annex A: Subject's glasses independence and light dependence Annex B: Quality of Vision (QoV) questionnaire</description>
  </other_outcome>
  <other_outcome>
    <measure>Operative Complications / Postoperative Complications / Adverse Event Assessment</measure>
    <time_frame>6 months</time_frame>
    <description>Assessment of Operative Complications, Postoperative Complications, Adverse Events</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">66</enrollment>
  <condition>Cataract</condition>
  <condition>Presbyopia</condition>
  <arm_group>
    <arm_group_label>MINI WELL READY ®</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>BILATERAL IMPLANTATION OF MINI WELL READY®, A PROGRESSIVE EXTENDED DEPTH OF FOCUS INTRAOCULAR LENS IN PATIENTS WITH CATARACT SURGERY</description>
  </arm_group>
  <arm_group>
    <arm_group_label>FineVision ®</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>FINE VISION®, A TRIFOCAL INTRAOCULAR LENS IMPLANTATION IN PATIENTS WITH CATARACT SURGERY</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>MINI WELL READY ®</intervention_name>
    <description>BILATERAL IMPLANTATION OF MINI WELL READY®, A PROGRESSIVE EXTENDED DEPTH OF FOCUS INTRAOCULAR LENS IN PATIENTS WITH CATARACT SURGERY</description>
    <arm_group_label>MINI WELL READY ®</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>FINE VISION®</intervention_name>
    <description>FINE VISION®, A TRIFOCAL INTRAOCULAR LENS IMPLANTATION IN PATIENTS WITH CATARACT SURGERY</description>
    <arm_group_label>FineVision ®</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age ≥ 18 years

          -  Bilateral cataract surgery required, no other ocular comorbidities

          -  Healthy corneas, not treated surgically

          -  Available for second-eye surgery within 1 week of the initial operation

          -  Spherical refraction between -8.00D and +6.00D

          -  Willing to adhere to the study visit schedule

          -  Normal anterior and posterior segments

          -  Clear intraocular media - other than cataract

          -  To benefit from a social security system before being enrolled

          -  Written informed consent consistent with local regulation research in human subjects

        Exclusion Criteria:

          -  Any previous history of ocular trauma or prior ocular surgery (including previous
             cataract surgery and CLRIs)

          -  Ocular comorbidities determining potential postoperative Visual Acuity less than 0.50
             decimal (0.3 logMAR)

          -  Expected to require retinal laser treatment

          -  A history of retinal detachment or predisposition for such disorder

          -  Psudoexfoliation

          -  Abnormal pupil size and position

          -  Pupil size &gt; 7 mm under mesopic condition

          -  Use of contact lenses 30 days before the preoperative visit

          -  Corneal warpage (e.g. Keratoconus, Pellucid Marginal Corneal Degeneration or
             Keratoglobus)

          -  Corneal astigmatism greater than 0.75D

          -  Zonular laxicity

          -  Absence of adequate capsular support for the implant of the intraocular lens in the
             capsular bag

          -  Microphthalmus

          -  Active ocular disease in the operative eye, for example, chronic uveitis,
             proliferative diabetic retinopathy, chronic glaucoma unresponsive to medication,
             corneal decompensation and corneal endothelial cell insufficiency (such as Fuch's
             endothelial dystrophy)

          -  Suspected microbial infection

          -  Irregularities and capsulorexis decentralization

          -  Surgical difficulties that may increase the risk of complications such as persistent
             bleeding, significant iris damage, an uncontrollable intraocular hypertonia, or damage
             due to significant vitreous loss

          -  Patients in whom the intraocular lens may interfere with the ability to observe,
             diagnose or treat diseases of the posterior segment

          -  Patients in whom neither the posterior capsule nor the zonula can provide adequate
             support to the lens

          -  Subjects with any systemic disease that could increase operative risk or confound the
             outcome

          -  Pregnant or lactating or planning a pregnancy at the time of enrolment

          -  Vulnerable subjects (children &lt;18 years, people in guardianship or trusteeship or
             inability to give an informed consent)

          -  Subjects participating in a concurrent clinical trial or if they have participated in
             an ophthalmology clinical trial within the last 30 days
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Prof. Béatrice Cochener, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ophtalmologie Hôpital Morvan, Brest, France</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Gianluca Stivale, PharmD</last_name>
    <phone>+390957922335</phone>
    <email>gianluca.stivale@sifigroup.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Loretta Aureli</last_name>
    <phone>+39 3346975759</phone>
    <email>loretta.aureli@sifigroup.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Ophtalmologie Hôpital Morvan</name>
      <address>
        <city>Brest</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Prof. Béatrice Cochener, MD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <removed_countries>
    <country>Romania</country>
  </removed_countries>
  <verification_date>September 2019</verification_date>
  <study_first_submitted>February 18, 2017</study_first_submitted>
  <study_first_submitted_qc>February 18, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">February 23, 2017</study_first_posted>
  <last_update_submitted>September 30, 2019</last_update_submitted>
  <last_update_submitted_qc>September 30, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">October 1, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cataract</mesh_term>
    <mesh_term>Presbyopia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

